Table 4.
Subjects infected by SARS-CoV-2 per group (IM=intramuscular; IN=intranasal)
| Dose | Route/regimen Infected after 1st Dose | Route/regimen Infected after 2nd Dose | Total per dose level | ||||
|---|---|---|---|---|---|---|---|
| IM/IM | IN/IN | IN/IM | IM/IM | IN/IN | IN/IM | ||
| 107.0 EID50%/dose (LD) | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| 107.5 EID 50%/dose (MD) | 0 | 2 | 0 | 0 | 3 | 1 | 6 |
| 108.0 EID 50%/dose (HD) | 1 | 1 | 0 | 0 | 0 | 1 | 4 |
| Subtotal per route and administered doses | 2 | 3 | 0 | 0 | 3 | 2 | |